Regulatory & Legal

KB Home's new Port Orchard community isn't just about houses; it's a new model for building that merges personalization, deep energy savings, and market strategy.

Promising long-term data and key regulatory wins position Wugen's allogeneic therapy to disrupt the challenging T-cell cancer treatment landscape.

A shareholder lawsuit challenges Comerica's $10.9B sale to Fifth Third, citing a rushed process, CEO self-interest, and an undervalued price.

China Automotive Systems' new high-torque motor isn't just a component; it's a strategic play for the future of autonomous trucking and a challenge to incumbents.

As new laws bring clarity to digital currencies, WSPN is offering enterprises the tools to mint their own, accelerating a shift in global finance.

Henri Beaufour’s passing transfers a major Ipsen stake to a charity. We analyze the governance safeguards and what it means when philanthropy enters the boardroom.

TELUS just secured $2.3 billion in a complex debt offering. We decode the move and what it signals about its high-tech ambitions beyond telecom.

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

Virax secured a $5M runway for its Long COVID diagnostics, but the deal's terms reveal a high-stakes gamble involving significant shareholder dilution.

Tigerlily Foundation and Bristol Myers Squibb are using brunch to address dire racial disparities in clinical trials. Is this the future of health equity?

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

New polling reveals Gen Z's surprising conservative turn, driven not by ideology but a deep revolt against a system they believe has failed them.

A promising fintech's complex arbitrage strategy collapses, triggering a stock crash, CEO exit, and a wave of securities fraud investigations.

An agency wins top awards for its storytelling, but the real prize is finding homes for 11,000 kids. Can narrative change the fate of a system in crisis?

Mouser Electronics' sponsorship of DS PENSKE is more than a logo on a car. It’s a strategic investment in the future of EV tech and sustainable innovation.

MicroCloud Hologram is betting $400M on a quantum-driven 3D model. Is it a revolutionary leap for digital creation or a costly gamble on unproven tech?

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

A regulatory filing reveals Balyasny Asset Management's strategic trading in Just Group as the stock hits a 52-week high during a takeover.

Stricter safety rules are pressuring pharmacies. Discover how advanced software is helping them navigate complex regulations and protect patients from harm.